Latest Breaking News On - Subcutaneous epcoritamab - Page 1 : comparemela.com

Genmab A/S: Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

Genmab A/S: Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesEpcoritamab monotherapyEpcoritamab polatuzumab vedotinJudith klimovskyAndrew carlsenDavid freundelRituximab lenalidomideAccess libraryOutcomes researchProduct communicationsClinical researchA survey of healthcare professionalsGenmab us incPharmacokinetic translational researchExchange commission

Genmab to Present New and Updated Results From Multiple

Genmab to Present New and Updated Results From Multiple
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesEpcoritamab monotherapyJudith klimovskyPolatuzumab vedotinAndrew carlsenDavid freundelA survey of healthcare professionalsOutcomes researchClinical researchAccess libraryEuropean hematology associationExchange commissionPharmacokinetic translational researchProduct communicationsAbbvie biotechnology ltd

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesDavid freundelAndrew carlsenPolatuzumab vedotinEpcoritamab monotherapyJudith klimovskyCurtain raiser pressProduct communicationsPharmacokinetic translational researchAbbvie biotechnology ltdExchange commissionOutcomes researchA survey of healthcare professionalsAccess libraryEuropean hematology association

EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With Rituximab and Lenalidomide (R2) vs R2 Alone in Patients With Relapsed or Refractory Follicular Lymphoma

Lorenzo Falchi, MD, discusses the ongoing EPCORE FL-1 phase 3 trial investigating epcoritamab-rituximab-lenalidomide vs rituximab-lenalidomide in patients with relapsed or refractory follicular lymphoma.

United statesSan diegoLorenzo falchiDrug administrationEastern cooperative oncology groupSubcutaneous epcoritamab with rituximabPatients with relapsedRefractory follicularPartnership withNorth americaSouth americaSubcutaneous epcoritamabEpcore fl 1Follicular lymphomaRelapsed refractory follicular lymphomaEpcore fl 1 trial

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)

Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomSan diegoKalvebod bryggeDavid freundelHematol hemoterAndrew carlsenJudith klimovskyOutcomes researchAbbvie biotechnology ltdCompany announcementNational comprehensive cancer networkData from the observational national lymphocare studyDiscovery researchAmerican society of hematology